Greenwich LifeSciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Greenwich LifeSciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Greenwich LifeSciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $4.51M, a 43.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.51M +$1.37M +43.6% Dec 31, 2023 10-K 2024-04-15
Q4 2022 $3.14M +$1.28M +68.7% Dec 31, 2022 10-K 2024-04-15
Q4 2021 $1.86M +$821K +79% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $1.04M +$249K +31.5% Dec 31, 2020 10-K 2022-03-21
Q4 2019 $790K Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.